Despite the tremendous strides we have made against water-borne, food-borne, and vector-borne diseases, airborne infectious diseases remain one of humanity's biggest challenges.
Expression of Interest Deadline
August 21, 2026
All technical areas in this group share this deadline. Submit to biosurveillance-rfp@blueprintbiosecurity.org by 11:59 PM ET.
Biosurveillance, including early warning of emerging pathogens, is a key part of pandemic prevention. Early warning helps societies respond effectively to new outbreaks, whether naturally occurring, accidental, or deliberate in origin, enabling timely action to suppress transmission and develop countermeasures.
Today, most pathogen surveillance depends on recognizable clinical signals and targeted detection methods that require knowing what molecular features to look for in advance. These systems leave us poorly prepared for novel, engineered, or otherwise unexpected pathogens — key drivers of pandemic risk.
Metagenomic sequencing (MGS) is a promising, pathogen-agnostic detection platform that addresses critical limitations of relying solely on syndromic surveillance and targeted detection methods. By sequencing all nucleic acids in a sample, MGS has the potential to detect and genomically characterize any pathogen present without prior knowledge of what to look for. Falling sequencing costs and expanding biosurveillance infrastructure have made MGS more practical as a tool for broad, pathogen-agnostic detection.
The aim of this RFP is to accelerate the deployment and maturation of MGS as a biosurveillance platform by funding improved computational, laboratory, and modeling methods for early pathogen detection and characterization.
We invite Expressions of Interest (EOIs) from groups to investigate the following areas:
Across all three technical areas, we are particularly interested in work targeting human pathogens with pandemic potential, especially approaches that are scalable, grounded in real-world biosurveillance data, and openly available for broader use. Antimicrobial resistance, primarily amplicon- or PCR-based approaches, and tools for predicting pathogen immune evasion or pathogenicity are out of scope.
The full RFP below covers all three Technical Areas. It includes background, scope, general eligibility requirements, anticipated awards, and additional specific research questions for every Technical Area.
Depending on proposal quality, cost-effectiveness, and available funding, we may not make an award in every Technical Area, or we may make multiple awards in some Technical Areas. We anticipate that total awards will amount to $5 million.
We particularly value speed of execution and prefer proposals that reasonably aim to achieve their stated deliverables within 12 months or sooner.
Applicants interested in this work are required to submit an EOI summarizing their proposed approach. We encourage applicants to propose creative, rigorous methods for achieving the study objectives and to clearly explain how their approach will generate decision-relevant results.
All EOI submissions should be emailed to biosurveillance-rfp@blueprintbiosecurity.org.
Format and length:
Whether or not you use the provided template, your Expression of Interest must include:
Following the review of EOIs, selected applicants will receive a Notice of Recommendation and be invited to submit a Full Proposal within three weeks of notification.
A Full Proposal will consist of a technical section and a cost section. Templates and additional guidance will be provided to selected applicants.
Please email all administrative, technical, and contractual questions to biosurveillance-rfp@blueprintbiosecurity.org. Questions about this program that are not sent to this email may not be replied to. All questions must be submitted in English and include the sender's name, email address, and telephone number for follow-up.
When we determine that a response would be helpful to all parties interested in the RFP, we may post the question and answer in a public FAQ on our website. Questions may be paraphrased as needed to protect applicant information.